Pharmacological Management of Apathy in Dementia
In conclusion, there are currently no US FDA-approved drugs that target apathy in dementia, so there is an on going need for the development of such drugs.
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Alzheimer's | Cardiology | Cardiovascular | Celexa | Citalopram | Clinical Trials | Concerta | Dementia | Gastroenterology | Heart | Methylphenidate | Namenda | Neurology | Ritalin | Study | Zyprexa